ENTEROFURYL

Oral suspension, 200mg/5ml
RxActive license

Active substance (INN)

nifuroxazide

Pharmaceutical form

Pharmaceutical formOral suspension
Strength200mg/5ml
PackagingUkupno 1 bočica staklena sa 90ml oralne suspenzije u kartonskoj kutij
ManufacturerBosnalijek d.d., Bosnia and Herzegovina
Therapeutic groupAlimentary tract and metabolism (A07AX03)
Marketing authorization holderBOSNALIJEK D.D. PREDSTAVNIŠTVO CRNA GORA
Authorization dateJuly 8, 2024

Analogs in Montenegro

5

Other medicines with the same active substance

ENTEROFURYLRx
Capsule, hard, 200mgBosnalijek d.d.
ENTEROFURYLRx
Capsule, hard, 100mgBosnalijek d.d.
NIFUROKSAZID ALKALOIDRx
Oral suspension, 200mg/5mlAlkaloid AD Skopje
NIFUROKSAZID ALKALOIDRx
Capsule, hard, 100mgAlkaloid AD Skopje
NIFUROKSAZID ALKALOIDRx
Capsule, hard, 200mgAlkaloid AD Skopje
Source: CInMED register